Notice Number

NOTICES

Notice No.	20230320-2	Notice Date	20 Mar 2023

Category	Company related	Segment	Equity

Subject	Buyback of equity shares of NATCO PHARMA LIMITED (Scrip code: 524816)

Attachments	PA.pdf ;

Content

Trading Members are hereby informed that NATCO PHARMA LIMITED (Scrip code: 524816) has announced buyback of its fully paid-up equity shares of face value of Rs. 2/- each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs. 700/- (Rupees Seven Hundred only) per equity share payable in cash for an aggregate amount not exceeding Rs. 2,10,00,00,000/- (Rupees Two Hundred and Ten Crores only).

1. Proposed timetable for buyback:

Date of Opening of the Buyback

On Tuesday, March 21, 2023

Last Date for the Buyback

Earlier of:

a. September 20, 2023 (i.e. six (6) months from the date of the commencement of the Buyback); or

b. when the Company completes the Buyback by deploying the amount equivalent to the Maximum Buyback Size; or

c. at such earlier date as may be determined by the Board or its Committee of Directors, after giving notice of such earlier closure, subject to the Company having deployed an amount equivalent to the Minimum Buyback Size (even if the Maximum Buyback Size has not been

reached or the Maximum Buyback Shares have not been bought back), provided, that all payment obligations relating to the Buyback shall be completed before the last date for the Buyback

2. Broker Members for buyback:

The company has appointed the following BSE Trading Members through whom the purchases and settlement on account of the buyback would be made:

DAM Capital Advisors Limited

Address: One BKC, Tower C, 15th Floor, Unit No. 1511,

Bandra Kurla Complex, Bandra (East), Mumbai 400 051,

Maharashtra, India

Tel.: +91 22 4202 2500

Fax: +91 22-4202 2504

Email: rajesh@damcapital.in

Website : www.damcapital.in

Contact Person: Rajesh Tekadiwala

Clearing No: 0623

Client Code: BUYBACKNAT

3. Details of Shares held in DEMAT Form.

The Trading Members may note that the Equity Shares held in DEMAT form can be offered for Buyback to the Company in rolling settlement, as per details mentioned below:

Scrip Code	524816
Market Lot	1 Share
Scrip ID	NATCOPHARM*

4. Circuit Filters, Margins, Capital Adequacy Norms, Auction, Close out, Arbitration, etc. are applicable in case of buyback as in the case of the normal trading.

5. Institutional Investors are allowed to participate in the buyback.

6. Please note that, settlement will be with normal equity cash segment trades and market type for delivery will be “Normal” equity cash segment

7. The documents are available in Department of Corporate Services for inspection. In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:

Merchant Banker to the Buyback:

DAM Capital Advisors Limited

Address: One BKC, Tower C, 15th Floor Unit No. 1511, Bandra Kurla

Complex Bandra (East), Mumbai – 400 051 Maharashtra, India

Tel.: +91 22 4202 2500

Fax: +91 22-4202 2504

Contact Person: Chandresh Sharma

Email: natco.buyback@damcapital.in

Website: www.damcapital.in

SEBI Registration No.: MB/INM000011336

At the Company:

Name: Chekuri Venkat Ramesh